UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM SD
SPECIALIZED DISCLOSURE REPORT
MERIDIAN BIOSCIENCE, INC.
(Exact name of the registrant as specified in its charter)
 

Ohio
  
0-14902
  
31-0888197
(State or other jurisdiction of
  incorporation or organization)
  
(Commission File Number)
  
(IRS Employer
Identification No.)
         
 
3471 River Hills Drive
Cincinnati, Ohio
        45244
 (Address of principal executive offices)       (Zip code) 
 


Melissa A. Lueke
  
(513) 271-3700
(Name and telephone number, including area code, of
 the person to contact in connection with this report.)


Check the appropriate box to indicate the rule pursuant to which this form  is  being  filed, and  provide  the  period  to  which  the  information  in  this form applies:

  X    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2017.

___ Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _____________________________.





SECTION 1. CONFLICT MINERALS DISCLOSURE

Item 1.01  Conflict Minerals Disclosure and Report

Meridian Bioscience, Inc. ("Meridian" or the "Company") evaluated its products during the year ended December  31, 2017 and  determined  that  certain  products manufactured or contracted to be manufactured by the Company contain tin, tungsten, tantalum, and/or gold.  As a result, Meridian has filed a Conflict Minerals Report ("CMR"). A copy of Meridian's CMR is furnished as Exhibit 1.01 to this Form SD and is incorporated herein by reference. Copies of Meridian's Form SD and CMR are also available at the Meridian corporate website:  www.meridianbioscience.com.



SECTION 2. EXHIBITS

Item 2.01  Exhibits

Exhibit 1.01 Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

Date:   May 25, 2018
MERIDIAN BIOSCIENCE, INC.
 
 
By: /s/ Melissa A. Lueke                                                              
      Melissa A. Lueke
      Executive Vice President and
      Chief Financial Officer